Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chin-ho Chen

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Current Medicinal Chemistry|March 12, 2009
Proteasome regulators: activators and inhibitorsLi Huang, Chin Ho Chen
Current Drug Targets. Infectious Disorders|December 5, 2002
Molecular targets of anti-HIV-1 triterpenesLi Huang, Chin Ho Chen
Trends in Molecular Medicine|January 15, 2005
Betulinic acid derivatives as HIV-1 antiviralsChristopher Aiken, Chin Ho Chen
Biomolecules|October 16, 2014
Inhibitory effect of b-AP15 on the 20S proteasomeLi Huang, Katherine Jung, Chin Ho Chen
FEBS Letters|October 2, 2007
Activation and inhibition of the proteasome by betulinic acid and its derivativesLi Huang, Phong Ho, Chin-Ho Chen
Journal of Virology|October 13, 2006
Human immunodeficiency virus type 1 resistance to the small molecule maturation inhibitor 3-O-(3',3'-dimethylsuccinyl)-betulinic acid is conferred by a variety of single amino acid substitutions at the CA-SP1 cleavage site in GagJing Zhou, Chin Ho Chen, Christopher Aiken
Current Pharmaceutical Design|May 29, 2003
Potential drug targets on the HIV-1 envelope glycoproteins, gp120 and gp41Li Huang, Linda Zhang, Chin Ho Chen
Retrovirology|July 1, 2004
The sequence of the CA-SP1 junction accounts for the differential sensitivity of HIV-1 and SIV to the small molecule maturation inhibitor 3-O-{3',3'-dimethylsuccinyl}-betulinic acidJing Zhou, Chin Ho Chen, Christopher Aiken
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|February 26, 2011
HIV entry inhibitors: progress in development and applicationWei-hong Lai, Li Huang, Chin-ho Chen
Vaccine|June 14, 2003
Neutralization epitopes of the HIV-1 primary isolate DH012Chongbin Zhu, Thomas J Matthews, Chin Ho Chen
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Current Medicinal Chemistry|March 12, 2009
Proteasome regulators: activators and inhibitorsLi Huang, Chin Ho Chen
Current Drug Targets. Infectious Disorders|December 5, 2002
Molecular targets of anti-HIV-1 triterpenesLi Huang, Chin Ho Chen
Trends in Molecular Medicine|January 15, 2005
Betulinic acid derivatives as HIV-1 antiviralsChristopher Aiken, Chin Ho Chen
Biomolecules|October 16, 2014
Inhibitory effect of b-AP15 on the 20S proteasomeLi Huang, Katherine Jung, Chin Ho Chen
FEBS Letters|October 2, 2007
Activation and inhibition of the proteasome by betulinic acid and its derivativesLi Huang, Phong Ho, Chin-Ho Chen
Journal of Virology|October 13, 2006
Human immunodeficiency virus type 1 resistance to the small molecule maturation inhibitor 3-O-(3',3'-dimethylsuccinyl)-betulinic acid is conferred by a variety of single amino acid substitutions at the CA-SP1 cleavage site in GagJing Zhou, Chin Ho Chen, Christopher Aiken
Current Pharmaceutical Design|May 29, 2003
Potential drug targets on the HIV-1 envelope glycoproteins, gp120 and gp41Li Huang, Linda Zhang, Chin Ho Chen
Retrovirology|July 1, 2004
The sequence of the CA-SP1 junction accounts for the differential sensitivity of HIV-1 and SIV to the small molecule maturation inhibitor 3-O-{3',3'-dimethylsuccinyl}-betulinic acidJing Zhou, Chin Ho Chen, Christopher Aiken
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|February 26, 2011
HIV entry inhibitors: progress in development and applicationWei-hong Lai, Li Huang, Chin-ho Chen
Vaccine|June 14, 2003
Neutralization epitopes of the HIV-1 primary isolate DH012Chongbin Zhu, Thomas J Matthews, Chin Ho Chen
Pageof 13